Lloyds Engineering Works Share Price Jumps Over 2% After Signing 2 Agreements with Kliver Polska

Lloyds Engineering Works has entered into 2 contract agreements with Kliver Polska of Poland on November 20, 2025. These agreements focus on the development of specialised engineering systems to support the company’s operational capabilities. 

The first agreement covers the design, prototyping and delivery of a towed reel intended for a multifunctional underwater platform with a contract value of $1,63,900. The second agreement is for the design, prototyping and delivery of an operational test tilt stand valued at €3,10,000. Both agreements aim to support engineering requirements for advanced equipment development. 

Purpose and Scope of the New Agreements 

The towed reel project seeks to enable underwater platform operations by adding specialised handling capabilities. The test stand project focuses on creating an operational testing environment for tilt mechanisms. Kliver Polska will be responsible for delivering both systems as per the agreed scope, and the company has no shareholding relationship with Lloyds Engineering Works. 

Read More: EPACK Prefab Technologies Share Price Gains Over 7%; Signs MoU with MASCOT South Asia! 

Key Contract Terms and Additional Disclosures 

The agreements do not impose any restrictions or liabilities on Lloyds Engineering Works beyond the delivery obligations of Kliver Polska. Both deals are independent and do not involve related party transactions. They also do not result in any management or control changes at Lloyds Engineering Works, as no board representation or share issuance is part of the agreements. 

Lloyds Engineering Works Share Price Performance  

As of November 20, 2025, at 2:55 PM, Lloyds Engineering Works share price was trading at ₹56.65 up by 2.65% from the previous closing price. 

Conclusion 

The agreements between Lloyds Engineering Works and Kliver Polska mark a structured step towards developing new engineering components. With defined scopes and confirmed contract values, the collaborations align with the company’s ongoing operational objectives as disclosed to the exchanges. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.